European Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading
European equities traded in the US as American depositary receipts kicked off the week moving sharply higher late Monday morning, climbing 1.11% to 1,428.14 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and biopharmaceutical company Genfit (GNFT), which rose 5% and 2.5% respectively. They were followed by oil and gas company TotalEnergies (TTE) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which were up 1.6% and 1% respectively.
The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and furniture maker Natuzzi (NTZ), which lost 5.5% and 3.9% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Calliditas Therapeutics (CALT), which dropped 1.7% and 1.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and biotech firm Autolus Therapeutics (AUTL), which advanced 19.2% and 4% respectively. They were followed by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Verona Pharma (VRNA), which increased 3.2% and 3% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm (TCBP) and Akari Therapeutics (AKTX), which fell 19% and 5.8% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and construction materials supplier CRH (CRH), which were down 3.4% and 2% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。